Infectivity-Enhanced Adenoviruses for Improved Replicative Oncolysis

摘要

We have been developing conditionally replicative adenoviral agents (CRADs) for prostate cancer gene therapy. We have sought to improve these agents by increasing their infectivity for tumor targets and by enhancing the specificity of their replication exclusively within tumor targets.